Song Hae Geun, Kang Soo-Jin, Mintz Gary S
Department of Cardiology, DeltaHealth Hospital, Shanghai, China.
Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Echocardiography. 2018 Apr;35(4):520-533. doi: 10.1111/echo.13837.
There has been great effort to improve clinical outcome in percutaneous treatment for coronary artery disease. Complementary to coronary angiography, intravascular ultrasound (IVUS) provides in vivo tomographic anatomic information, enabling to evaluate from the lumen to the vessel wall. As a result, IVUS has had a pivotal role to understand pathophysiology of coronary artery disease and improve clinical outcome. It provides preprocedural information to evaluate stenosis severity and plaque characteristics and helps with optimal stent deployment, minimizing underexpansion and geographic miss that are the major mechanisms of stent failure. Recently, many large-scale clinical trials and meta-analyses with drug-eluting stents have shown the clinical benefits of IVUS-guided percutaneous coronary intervention. Some recent studies have also supported the cost-effectiveness of IVUS-guided PCI especially in high-risk patients. This article will discuss the clinical value of IVUS in contemporary practice.
在改善冠状动脉疾病经皮治疗的临床结果方面已付出巨大努力。血管内超声(IVUS)作为冠状动脉造影的补充,可提供体内断层解剖信息,能够从管腔到血管壁进行评估。因此,IVUS在理解冠状动脉疾病的病理生理学和改善临床结果方面发挥了关键作用。它提供术前信息以评估狭窄严重程度和斑块特征,并有助于优化支架置入,将支架扩张不足和地理性遗漏(支架失败的主要机制)降至最低。最近,许多关于药物洗脱支架的大规模临床试验和荟萃分析已显示出IVUS引导下经皮冠状动脉介入治疗的临床益处。一些近期研究也支持IVUS引导下PCI的成本效益,特别是在高危患者中。本文将讨论IVUS在当代实践中的临床价值。